Bedside Racism; COVID-19, Cancer, and Mortality; Genital Shrinkage – MedPage Today

A Black oncologist reflects on being caught off guard by a patient’s racist observation. (Journal of Clinical Oncology)

Research continues to be the driving force behind advances in cancer treatment, according to the 10th American Association for Cancer Research cancer progress report.

Patients with previously treated advanced/metastatic urothelial cancer lived significantly longer in a phase III trial when treated with enfortumab vedotin-ejfv (Padcev) instead of chemotherapy, according to Seattle Genetics and Astellas.

Alterations in gut bacteria (microbiome) may influence the effectiveness of chemotherapy for breast cancer. (European Breast Cancer Conference)

Older age and comorbid conditions may explain the increased mortality among patients with cancer and COVID-19. (ExBulletin)

Treatment delay may explain racial disparities in breast cancer mortality. (Cancer)

A combination of three commonly used drugs — aspirin, statins, and metformin — was associated with lower risk of developing or dying of lung cancer. (International Association for the Study of Lung Cancer)

Another type of commonly used medication — proton pump inhibitors — may blunt the effects of immunotherapy in bladder cancer. (American Association for Cancer Research)

About that executive order by President Trump on drug pricing — don’t hold your breath waiting for an impact on prices actually paid. (GlobalData)

Patients with advanced cancers involving the pelvic region obtained substantial pain relief from pulsed re-irradiation of areas previously treated with radiation. (Fox Chase Cancer Center)

Let’s talk about prostate cancer treatment and genital shrinkage … or not. (ASCO Connection)

  • author['full_name']

    Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined MedPage Today in 2007. Follow

Leave a Reply

Your email address will not be published. Required fields are marked *